Comments on the Pathophysiological Basis and Rationale for Early Treatment of COVID-19.
作者信息
Weissmann Leonardo, Barbosa Alexandre Naime, Scarpellini Bruno, Diament Décio, Medeiros Eduardo Alexandrino, Silva Estevão Urbano, Morejón Karen Mirna Loro, Oliveira Priscila Rosalba Domingos, Stucchi Raquel Silveira Bello, Medeiros Roseane Porto, Cimerman Sérgio, Vergara Tânia Regina Constant, Cunha Clóvis Arns
机构信息
Instituto de Infectologia Emílio Ribas, Sao Paulo, SP, Brazil.
Departamento de Infectologia, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brazil.
出版信息
Am J Med. 2021 May;134(5):e341-e342. doi: 10.1016/j.amjmed.2021.01.004.
Abstract
摘要
相似文献
1
Comments on the Pathophysiological Basis and Rationale for Early Treatment of COVID-19.关于2019冠状病毒病早期治疗的病理生理基础及理论依据的评论
Am J Med. 2021 May;134(5):e341-e342. doi: 10.1016/j.amjmed.2021.01.004.
2
The Reply.回复。
Am J Med. 2021 Mar;134(3):e222-e223. doi: 10.1016/j.amjmed.2020.10.036.
3
The Reply.回复。
Am J Med. 2021 Apr;134(4):e298. doi: 10.1016/j.amjmed.2020.11.028.
4
The Reply.回复。
Am J Med. 2021 May;134(5):e346-e347. doi: 10.1016/j.amjmed.2021.01.013.
5
The Reply.回复。
Am J Med. 2021 May;134(5):e343-e344. doi: 10.1016/j.amjmed.2021.01.011.
6
Engaging and Empowering the Front Lines During the COVID-19 Outpatient Practice Reactivation.在新冠疫情门诊恢复运营期间调动一线人员积极性并赋予其权力
Mayo Clin Proc. 2020 Sep;95(9S):S47-S51. doi: 10.1016/j.mayocp.2020.06.040. Epub 2020 Jun 30.
7
Early Outpatient Treatment of SARS-CoV-2 (COVID-19): A Comment.严重急性呼吸综合征冠状病毒2型（新冠病毒）的早期门诊治疗：一则评论
Am J Med. 2021 Mar;134(3):e220-e221. doi: 10.1016/j.amjmed.2020.08.044.
8
Outpatient Evaluation and Management of COVID-19.COVID-19 的门诊评估与管理。
Ann Intern Med. 2022 Apr;175(4):590-591. doi: 10.7326/M22-0403. Epub 2022 Feb 15.
9
[Not Available].[无可用内容]
MMW Fortschr Med. 2022 Jan;164(1):24-26. doi: 10.1007/s15006-021-0542-z.
10
Risk of COVID-19 Transmission from Infected Outpatients to Healthcare Workers in an Outpatient Clinic.感染门诊患者对门诊医护人员发生 COVID-19 传播的风险。
J Korean Med Sci. 2020 Dec 28;35(50):e431. doi: 10.3346/jkms.2020.35.e431.
本文引用的文献
1
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.COVID-19 重症患者全身使用皮质类固醇与死亡率的关联：一项荟萃分析。
JAMA. 2020 Oct 6;324(13):1330-1341. doi: 10.1001/jama.2020.17023.
2
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection.SARS-CoV-2（COVID-19）感染早期门诊治疗的病理生理基础和原理。
Am J Med. 2021 Jan;134(1):16-22. doi: 10.1016/j.amjmed.2020.07.003. Epub 2020 Aug 7.
3
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
4
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.纽约州 COVID-19 患者住院死亡率与羟氯喹或阿奇霉素治疗的关联。
JAMA. 2020 Jun 23;323(24):2493-2502. doi: 10.1001/jama.2020.8630.
Zotero 插件